18F-BMS-986229
Showing 1 - 25 of 2,359
Healthy Participants, Idiopathic Pulmonary Fibrosis (IPF) Trial in New Haven (18F-BMS-986327)
Recruiting
- Healthy Participants
- Idiopathic Pulmonary Fibrosis (IPF)
- 18F-BMS-986327
-
New Haven, ConnecticutYale Positron Emission Tomography Center
Mar 30, 2022
Cancer Head Neck, Metastatic Cancer, Metastatic Lung Cancer Trial in New Haven (adnectin 18F-BMS-986192 Head and Neck Cancer,
Not yet recruiting
- Cancer Head Neck
- +2 more
- adnectin 18F-BMS-986192 Head and Neck Cancer
- adnectin 18F-BMS-986192 Brain Metastases
-
New Haven, ConnecticutYale University PET Center
Oct 10, 2022
Stage II Nasopharyngeal Carcinoma AJCC v8, Stage III Nasopharyngeal Carcinoma AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8
Not yet recruiting
- Stage II Nasopharyngeal Carcinoma AJCC v8
- +2 more
- Biopsy
- +16 more
- (no location specified)
Oct 7, 2023
Oral Cavity Squamous Cell Carcinoma Trial in Amsterdam (Nivolumab)
Active, not recruiting
- Oral Cavity Squamous Cell Carcinoma
-
Amsterdam, Noord-Holland, NetherlandsVU University medical center
Oct 6, 2021
Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)
Not yet recruiting
- Advanced Cancer
- Clear Cell Renal Cell Carcinoma
- 177Lu girentuximab
- +3 more
-
Houston, TexasMD Anderson Cancer Center
Dec 15, 2022
Melanoma Trial in Groningen (PD-L1 PET imaging)
Completed
- Melanoma
- PD-L1 PET imaging
-
Groningen, NetherlandsUMCG
Apr 26, 2021
Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)
Not yet recruiting
- Classic Hodgkin Lymphoma
- Biospecimen Collection
- +19 more
- (no location specified)
Jan 6, 2023
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Detroit (drug, radiation,
Completed
- Adenocarcinoma of the Prostate
- +3 more
- cabozantinib-s-malate
- +4 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Aug 3, 2021
Esophageal Cancer, Intensity-modulated Radiation Therapy, Concurrent Chemoradiotherapy Trial in Beijing (rhTPO)
Not yet recruiting
- Esophageal Cancer
- +3 more
-
Beijing, Beijing, ChinaDepartment of Radiation Oncology, Cancer Institute and Hospital,
Jul 12, 2023
Advanced Cancer Trial in Hangzhou (BMS-986205, Nivolumab)
Completed
- Advanced Cancer
- BMS-986205
- Nivolumab
-
Hangzhou, Zhejiang, ChinaLocal Institution
Feb 3, 2022
Migraine, Acute Treatment of Migraine Trial in United States (Rimegepant, Placebo, Sumatriptan)
Completed
- Migraine
- Acute Treatment of Migraine
- Rimegepant
- +2 more
-
Scottsdale, Arizona
- +40 more
Dec 15, 2022
[18F]Florbetazine for Beta Amyloid PET Imaging in Alzheimer's
Recruiting
- Alzheimer's Disease
- [18F]Florbetazine ([18F]92)
- [11C]PIB
-
Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hop
Nov 19, 2023
Lobular Breast Carcinoma Trial in Monaco (68Ga-FAPI-46 PET scan)
Not yet recruiting
- Lobular Breast Carcinoma
- 68Ga-FAPI-46 PET scan
-
Monaco, MonacoCentre Hospitalier Princesse Grace
Jun 27, 2023
Active Psoriatic Arthritis Trial in Worldwide (BMS-986165 Placebo, BMS-986165 Dose A, BMS-986165 Dose B)
Completed
- Active Psoriatic Arthritis
- BMS-986165 Placebo
- +4 more
-
Huntsville, Alabama
- +93 more
Jan 25, 2022
Calcium Citrate Absorption, Calcium Carbonate Absorption Trial in Alexandria (The absorption effect between calcium citrate and
Not yet recruiting
- Calcium Citrate Absorption
- Calcium Carbonate Absorption
- The absorption effect between calcium citrate and calcium carbonate
-
Alexandria, EgyptThe surgical department of Medical Research Institute Hospital,
Sep 15, 2023
Burning Mouth Syndrome Trial (drug, other, dietary supplement, radiation)
Not yet recruiting
- Burning Mouth Syndrome
- topical placebo tablet
- +5 more
- (no location specified)
Sep 10, 2023
Breast Cancer Trial in Madison (drug, device, other)
Not yet recruiting
- Breast Cancer
- 18F-fluorofuranylnorprogesterone
- +4 more
-
Madison, WisconsinUW Carbone Cancer Center
Oct 11, 2023
Pulmonary Fibrosis Trial in Worldwide (BMS-986278 Placebo, BMS-986278)
Active, not recruiting
- Pulmonary Fibrosis
- BMS-986278 Placebo
- BMS-986278
-
Birmingham, Alabama
- +118 more
Dec 3, 2022
18F-LN1 PET/CT in Urothelial Carcinomas
Recruiting
- Urothelial Carcinoma
-
Chengdu, Sichuan, ChinaDepartments of Nuclear Medicine, Sichuan Provincial People's Hos
Nov 2, 2023
Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston
Not yet recruiting
- Advanced Prostate Cancer
- +2 more
- 18F-fluciclovine
- PET/CT
-
Boston, Massachusetts
- +1 more
Sep 25, 2023